Financial Ratios

ELDER PHARMACEUTICALS LTD.

NSE : NABSE : 532322ISIN CODE : INE975A01015Industry : Pharmaceuticals & DrugsHouse : Elder
BSE38.000 (0 %)
PREV CLOSE ( ) 38.00
OPEN PRICE ( ) 38.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20547
TODAY'S LOW / HIGH ( )37.10 38.00
52 WK LOW / HIGH ( ) 37.138
NSE
This Company is not listed in NSE
Select year
ParticularsJun2014Jun2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)3.8645.6440.9434.4729.37
   CEPS(Rs)18.0663.4354.3947.5638.27
   DPS(Rs)0.000.003.003.003.00
   Book NAV/Share(Rs)382.51378.73336.82297.56251.70
   Tax Rate(%)55.6218.9918.7820.5214.36
Margin Ratios
   Core EBITDA Margin(%)-18.0721.6120.3220.7217.56
   EBIT Margin(%)57.0020.3719.3517.9116.27
   Pre Tax Margin(%)3.669.2910.4010.509.12
   PAT Margin (%)1.627.538.458.347.81
   Cash Profit Margin (%)7.6010.4611.2311.5110.17
Performance Ratios
   ROA(%)0.384.785.235.335.30
   ROE(%)1.0112.7612.9113.0412.45
   ROCE(%)16.8514.5313.1212.7212.51
   Asset Turnover(x)0.240.640.620.640.68
   Sales/Fixed Asset(x)0.781.961.661.531.87
   Working Capital/Sales(x)-7.48-8.777.324.151.42
Efficiency Ratios
   Fixed Capital/Sales(x)1.270.510.600.650.54
   Receivable days154.5289.8293.7690.3395.40
   Inventory Days70.0555.7774.5070.4459.33
   Payable days60.3035.6334.1340.6842.05
Valuation Parameters
   PER(x)56.397.148.2711.3212.22
   PCE(x)12.055.146.228.209.38
   Price/Book(x)0.570.861.011.311.43
   Yield(%)0.000.000.890.770.84
   EV/Net Sales(x)1.051.391.471.551.64
   EV/Core EBITDA(x)-6.945.826.407.068.74
   EV/EBIT(x)1.826.787.538.5410.01
   EV/CE(x)0.260.780.850.871.00
   M Cap / Sales0.920.540.710.960.96
Growth Ratio
   Net Sales Growth(%)-60.7925.2317.4219.3213.35
   Core EBITDA Growth(%)-124.7130.3923.1839.0323.00
   EBIT Growth(%)9.5631.7626.6931.6220.29
   PAT Growth(%)-91.5511.5018.7627.809.38
   EPS Growth(%)-91.5511.5018.7617.359.38
Financial Stability Ratios
   Total Debt/Equity(x)0.761.461.281.231.17
   Current Ratio(x)0.920.831.231.415.13
   Quick Ratio(x)0.900.660.861.053.96
   Interest Cover(x)1.071.842.162.422.27
   Total Debt/Mcap(x)1.341.701.270.930.82

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.